|
Sep 29
|
1 Under-the-Radar Biotech Stock to Buy and Hold
|
|
Aug 27
|
Axsome Therapeutics to Participate in Investor Conferences in September
|
|
Jul 30
|
Axsome Therapeutics, Inc.'s (NASDAQ:AXSM) Shift From Loss To Profit
|
|
Jul 30
|
Zacks Industry Outlook Highlights Moderna, Sarepta Therapeutics, Halozyme Therapeutics, Krystal Biotech and Axsome Therapeutics
|
|
Jul 23
|
7 Biotech Stocks to Keep on Your Clinical Radar
|
|
Jun 19
|
Investors ignore increasing losses at Axsome Therapeutics (NASDAQ:AXSM) as stock jumps 7.0% this past week
|
|
Jun 11
|
Why Axsome Therapeutics Stock Is Sinking Today
|
|
May 18
|
3 Monster Stocks in the Making You Can Buy Right Now
|
|
May 13
|
15 Most Depressed States in the US
|
|
May 11
|
The 3 Most Undervalued Biotech Stocks to Buy in May 2024
|
|
May 11
|
Prediction: These 2 Growth Stocks Could Triple By 2030
|
|
May 9
|
Axsome Therapeutics, Inc. (NASDAQ:AXSM) First-Quarter Results: Here's What Analysts Are Forecasting For This Year
|
|
May 8
|
Axsome Therapeutics to Present at Upcoming Investor Conferences
|
|
May 7
|
Axsome (AXSM) Q1 Loss Widens Y/Y, Revenues Beat Estimates
|
|
May 7
|
Axsome Therapeutics, Inc. (NASDAQ:AXSM) Q1 2024 Earnings Call Transcript
|
|
May 7
|
Axsome Therapeutics Inc (AXSM) (Q1 2024) Earnings Call Transcript Highlights: Soaring Revenues ...
|
|
May 7
|
Q1 2024 Axsome Therapeutics Inc Earnings Call
|
|
May 6
|
Axsome Therapeutics (AXSM) Q1 2024 Earnings Call Transcript
|
|
May 6
|
Axsome Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
|
|
May 3
|
Should You Buy Axsome Therapeutics (AXSM) Ahead of Earnings?
|